The mammalian target of rapamycin, mTOR, is a key element in a signaling pathway that controls mRNA translation and cell proliferation. mTOR is a member of a family of protein Ser/Thr kinases that have catalytic domains homologous to that of the catalytic subunit of phosphatidylinositol 3-OH kinase. How the protein kinase activity of mTOR is controlled is not known, and the downstream effectors and targets in the mTOR pathway have not been fully defined.
In Aim 1 of this proposal, the role of phosphorylation in controlling mTOR will be investigated. Insulin increases the protein kinase activity of mTOR and promotes the phosphorylation of one or more sites in a putative regulatory domain near the COOH terminus of mTOR. Binding of an antibody to this region also increases the kinase activity. We will attempt to determine whether phosphorylation of this domain directly activates mTOR or recruits an activating binding protein. The hypothesis that changes in the phosphorylation of sites in this domain are required for effects of insulin, amino acids or cAMP on cellular events controlled by the mTOR pathway will be tested. In Saccharomyces cerevisiae the effects of Tor1p and Tor2p, the yeast counterparts of mTOR, appear to be mediated by proteins homologous to protein phosphatase 2A (PP2A) and alpha4 protein.
In Aim 2 the potential role of alpha4 as an effector of mTOR will be investigated. The hypothesis that mTOR- dependent phosphorylation of alpha4 decreases PP2A activity by promoting formation of an alpha4-PP2A complex will be tested.
Aim 3 is to identify new downstream targets of the mTOR pathway. Chromatographic methods followed by either one- or two- dimensional electrophoresis will be used to resolve proteins whose phosphorylation is changed in response to rapamycin, a potent inhibitor of mTOR function. A newly developed method involving mixed peptide sequencing and data base searching will be used to identify the candidates. We hope that finding new targets will provide insight into the mechanisms involved in mTOR signaling and suggest new directions for future research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052753-06
Application #
6381353
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Blondel, Olivier
Project Start
1996-09-21
Project End
2005-06-30
Budget Start
2001-08-01
Budget End
2002-07-31
Support Year
6
Fiscal Year
2001
Total Cost
$325,077
Indirect Cost
Name
University of Virginia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Glidden, Emily J; Gray, Lisa G; Vemuru, Suneil et al. (2012) Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein. J Biol Chem 287:581-8
Harris, Thurl E; Finck, Brian N (2011) Dual function lipin proteins and glycerolipid metabolism. Trends Endocrinol Metab 22:226-33
Kumar, Anil; Lawrence Jr, John C; Jung, Dae Young et al. (2010) Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 59:1397-406
Liu, Guang-Hui; Qu, Jing; Carmack, Anne E et al. (2010) Lipin proteins form homo- and hetero-oligomers. Biochem J 432:65-76
Blancquaert, Sara; Wang, Lifu; Paternot, Sabine et al. (2010) cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Mol Endocrinol 24:1453-68
Kim, Hyun Bae; Kumar, Anil; Wang, Lifu et al. (2010) Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol Cell Biol 30:3126-39
Gropler, Matthew C; Harris, Thurl E; Hall, Angela M et al. (2009) Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J Biol Chem 284:6763-72
Wang, Lifu; Lawrence Jr, John C; Sturgill, Thomas W et al. (2009) Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR. J Biol Chem 284:14693-7
Sturgill, Thomas W; Hall, Michael N (2009) Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha. ACS Chem Biol 4:999-1015
Chen, Zhouji; Gropler, Matthew C; Norris, Jin et al. (2008) Alterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion. Arterioscler Thromb Vasc Biol 28:1738-44

Showing the most recent 10 out of 31 publications